Incidence of intracranial germ cell tumors by race in the United States, 1992–2010

Journal of Neuro-Oncology

Volumn 120, Issue 2, 2014, Pages 381-388

  Poynter, Jenny N ^a,b   Fonstad, Rachel ^a   Tolar, Jakub ^a,b,c   Spector, Logan G ^a,b   Ross, Julie A ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Germ cell tumors; Incidence; Intracranial; Pediatric cancer; SEER

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; FEMALE; GENETIC SUSCEPTIBILITY; GERM CELL TUMOR; GROUPS BY AGE; HUMAN; INTRACRANIAL GERM CELL TUMOR; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; PINEAL BODY TUMOR; SAMPLE SIZE; SURVIVAL RATE; TUMOR LOCALIZATION; UNITED STATES; YOUNG ADULT; BRAIN NEOPLASMS; CANCER REGISTRY; CANCER STAGING; ETHNIC GROUP; FOLLOW UP; INCIDENCE; INFANT; NEOPLASMS, GERM CELL AND EMBRYONAL; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; TIME;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84910148803     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1562-7     Document Type: Article

References (57)

1. Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210–222. doi:10.1038/nrc1568
2. Oosterhuis JW, Stoop H, Honecker F, Looijenga LH (2007) Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. Int J Androl 30: 256–263; discussion 263–254 doi: 10.1111/j.1365-2605.2007.00793.x
3. Arora RS, Alston RD, Eden TO, Geraci M, Birch JM (2012) Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer 118:4290–4297. doi:10.1002/cncr.27403
4. Jennings MT, Gelman R, Hochberg F (1985) Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg 63:155–167. doi:10.3171/jns.1985.63.2.0155
5. Carlos Chung KH, Owler BK, Dexter M, Chaseling R (2013) Paediatric germ cell tumours of the central nervous system: results and experience from a tertiary-referral paediatric institution in Australia. J Clin Neurosci 20:514–519. doi:10.1016/j.jocn.2012.04.017
6. McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, Matsuda A, Matsuda T, Sobue T, Palis BE, Dolecek TA, Kruchko C, Engelhard HH, Villano JL (2012) Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro Oncol 14:1194–1200. doi:10.1093/neuonc/nos155
7. Jellinger K (1973) Primary intracranial germ cell tumours. Acta Neuropathol 25:291–306
8. Villano JL, Propp JM, Porter KR, Stewart AK, Valyi-Nagy T, Li X, Engelhard HH, McCarthy BJ (2008) Malignant pineal germ-cell tumors: an analysis of cases from three tumor registries. Neuro Oncol 10:121–130. doi:10.1215/15228517-2007-054
9. Parkin DM, Kramarova E, Draper GJ, Masuyer E, Michaelis J, Neglia J, Qureshi S, Stiller CA (eds) (1998) International incidence of childhood cancer. International Agency for Research on Cancer. World Health Organization, Lyon
10. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19:1151–1159. doi:10.1158/1055-9965.EPI-10-0031
11. Surveillance, epidemiology, and end results (SEER) program. SEER*Stat Database: incidence—SEER 14 Regs Research Data, Nov 2011 Sub (1992–2010). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2013, based on the November 2012 submission. http://www.seer.cancer.gov
12. Linabery AM, Ross JA (2008) Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer 112:416–432. doi:10.1002/cncr.23169
13. Linabery AM, Ross JA (2008) Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975–1999. Cancer 113:2575–2596. doi:10.1002/cncr.23866
14. Howlader N, Noone A, Krapcho M, Garshell J, Neyman N, Altekruse S, Kosary C, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis D, Chen H, Feuer E, Cronin K (2013) SEER cancer statistics review, 1975–2010, National cancer institute. http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013
15. Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76:2343–2350
16. World Health Organization (2000) International classification of diseases for oncology, 3rd edn. WHO, Geneva
17. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P (2005) International classification of childhood cancer, third edition. Cancer 103:1457–1467. doi:10.1002/cncr.20910
18. Surveillance research program, national cancer institute, SEER*Stat software Version 8.1.2. www.seer.cancer.gov/seerstat
19. Ederer F, Axtell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101–121
20. McCarthy BJ, Kruchko C, Central Brain Tumor Registry of the United States (2005) Consensus conference on cancer registration of brain and central nervous system tumors. Neuro Oncol 7:196–201. doi:10.1215/S115285170400050X
21. Goodwin TL, Sainani K, Fisher PG (2009) Incidence patterns of central nervous system germ cell tumors: a SEER Study. J Pediatr Hematol Oncol 31:541–544. doi:10.1097/MPH.0b013e3181983af5
22. Makino K, Nakamura H, Yano S, Kuratsu J (2010) Population-based epidemiological study of primary intracranial tumors in childhood. Childs Nerv Syst 26:1029–1034. doi:10.1007/s00381-010-1126-x
23. Bauchet L, Rigau V, Mathieu-Daude H, Fabbro-Peray P, Palenzuela G, Figarella-Branger D, Moritz J, Puget S, Bauchet F, Pallusseau L, Duffau H, Coubes P, Tretarre B, Labrousse F, Dhellemmes P (2009) Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol 92:87–98. doi:10.1007/s11060-008-9740-0
24. Wong TT, Ho DM, Chang KP, Yen SH, Guo WY, Chang FC, Liang ML, Pan HC, Chung WY (2005) Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer 104:2156–2167. doi:10.1002/cncr.21430
25. Poynter JN, Amatruda JF, Ross JA (2010) Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006. Cancer 116:4882–4891. doi:10.1002/cncr.25454
26. Ducore JM, Parikh-Patel A, Gold EB (2004) Cancer occurrence in Southeast Asian children in California. J Pediatr Hematol Oncol 26:613–618
27. Motta PM, Nottola SA, Makabe S (1997) Natural history of the female germ cell from its origin to full maturation through prenatal ovarian development. Eur J Obstet Gynecol Reprod Biol 75:5–10
28. Moller H, Evans H (2003) Epidemiology of gonadal germ cell cancer in males and females. Apmis 111: 43–46; discussion 46–48
29. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L, Cogliano V (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 8:1065–1066
30. Wang XS, Tipper S, Appleby PN, Allen NE, Key TJ, Travis RC (2014) First-morning urinary melatonin and breast cancer risk in the Guernsey Study. Am J Epidemiol 179:584–593. doi:10.1093/aje/kwt302
31. Brzezinski A (1997) Melatonin in humans. N Engl J Med 336:186–195. doi:10.1056/NEJM199701163360306
32. Srinivasan V, Spence WD, Pandi-Perumal SR, Zakharia R, Bhatnagar KP, Brzezinski A (2009) Melatonin and human reproduction: shedding light on the darkness hormone. Gynecol Endocrinol 25:779–785. doi:10.3109/09513590903159649
33. Cavallo A (1993) Melatonin and human puberty: current perspectives. J Pineal Res 15:115–121
34. Cohen HN, Hay ID, Annesley TM, Beastall GH, Wallace AM, Spooner R, Thomson JA, Eastwold P, Klee GG (1982) Serum immunoreactive melatonin in boys with delayed puberty. Clin Endocrinol 17:517–521
35. Molina-Carballo A, Munoz-Hoyos A, Martin-Garcia JA, Uberos-Fernandez J, Rodriguez-Cabezas T, Acuna-Castroviejo D (1996) 5-Methoxytryptophol and melatonin in children: differences due to age and sex. J Pineal Res 21:73–79
36. Sethi RV, Marino R, Niemierko A, Tarbell NJ, Yock TI, Macdonald SM (2013) Delayed diagnosis in children with intracranial germ cell tumors. J Pediatr. doi:10.1016/j.jpeds.2013.06.024
37. Jorsal T, Rorth M (2012) Intracranial germ cell tumours. A review with special reference to endocrine manifestations. Acta Oncol 51:3–9. doi:10.3109/0284186X.2011.586000
38. Crawford JR, Santi MR, Vezina G, Myseros JS, Keating RF, LaFond DA, Rood BR, MacDonald TJ, Packer RJ (2007) CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis. Neurology 68:1668–1673. doi:10.1212/01.wnl.0000261908.36803.ac
39. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098
40. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66:11–18. doi:10.1002/ana.21756
41. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667. doi:10.1093/brain/awq113
42. Luca N, Daengsuwan T, Dalmau J, Jones K, deVeber G, Kobayashi J, Laxer RM, Benseler SM (2011) Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum 63:2516–2522. doi:10.1002/art.30437
43. Armangue T, Petit-Pedrol M, Dalmau J (2012) Autoimmune encephalitis in children. J Child Neurol 27:1460–1469. doi:10.1177/0883073812448838
44. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36. doi:10.1002/ana.21050
45. Lo JW, Leung EY, Ng BL, Fu MH, Yip KK, Chan RT, Chang CM (2010) Anti-N-methyl-D-aspartate receptor encephalitis in a young woman with an ovarian tumour. Hong Kong Med J 16:313–316
46. Roberts R, MacDougall NJ, O’Brien P, Abdelaziz K, Christie J, Swingler R (2012) Not hysteria: ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis. Scott Med J 57:182. doi:10.1258/smj.2012.012026
47. Dabner M, McCluggage WG, Bundell C, Carr A, Leung Y, Sharma R, Stewart CJ (2012) Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Int J Gynecol Pathol 31:429–437. doi:10.1097/PGP.0b013e31824a1de2
48. Dulcey I, Cespedes MU, Ballesteros JL, Preda O, Aneiros-Fernandez J, Clavero PA, Nogales FF (2012) Necrotic mature ovarian teratoma associated with anti-N-methyl-D-aspartate receptor encephalitis. Pathol Res Pract 208:497–500. doi:10.1016/j.prp.2012.05.018
49. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA (2012) The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 54:899–904. doi:10.1093/cid/cir1038
50. Fijak M, Meinhardt A (2006) The testis in immune privilege. Immunol Rev 213:66–81. doi:10.1111/j.1600-065X.2006.00438.x
51. Meinhardt A, Hedger MP (2011) Immunological, paracrine and endocrine aspects of testicular immune privilege. Mol Cell Endocrinol 335:60–68. doi:10.1016/j.mce.2010.03.022
52. Ransohoff RM, Kivisakk P, Kidd G (2003) Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3:569–581. doi:10.1038/nri1130
53. Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC (2006) CNS immune privilege: hiding in plain sight. Immunol Rev 213:48–65. doi:10.1111/j.1600-065X.2006.00441.x
54. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(Suppl 5):v1–49. doi:10.1093/neuonc/nos218
55. Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner C, Harms D, Gobel U (1999) Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol 17:2585–2592
56. SEER Characteristics of the SEER population compared with the total United States population. National Cancer Institute. http://seer.cancer.gov/registries/characteristics.html
57. Merrill RM, Dearden KA (2004) How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States? Cancer Causes Control 15:1027–1034